MARKET

CLNN

CLNN

Clene
NASDAQ
3.170
+0.340
+12.01%
After Hours: 3.300 +0.13 +4.09% 19:11 04/24 EDT
OPEN
2.910
PREV CLOSE
2.830
HIGH
3.490
LOW
2.892
VOLUME
414.88K
TURNOVER
--
52 WEEK HIGH
9.20
52 WEEK LOW
2.570
MARKET CAP
27.36M
P/E (TTM)
-0.5595
1D
5D
1M
3M
1Y
5Y
1D
Clene Initiated at Buy by Jones Trading
Dow Jones · 1d ago
Clene Price Target Announced at $30.00/Share by Jones Trading
Dow Jones · 1d ago
Jones Trading Initiates Coverage On Clene with Buy Rating, Announces Price Target of $30
Benzinga · 1d ago
Optimistic Outlook on Clene’s CNM-Au8 for ALS: Investment Potential Amid Clinical Challenges
TipRanks · 1d ago
Clene initiated with a Buy at JonesResearch
TipRanks · 1d ago
CLENE INC. <CLNN.O>: JONESTRADING INITIATES COVERAGE WITH BUY RATING; TARGET PRICE $30
Reuters · 2d ago
Weekly Report: what happened at CLNN last week (0414-0418)?
Weekly Report · 3d ago
Weekly Report: what happened at CLNN last week (0407-0411)?
Weekly Report · 04/14 11:45
More
About CLNN
More
Clene Inc. is a late clinical-stage biopharmaceutical company focused on improving mitochondrial health and protecting neuronal function to treat neurodegenerative diseases, including amyotrophic lateral sclerosis, Parkinson's disease, and multiple sclerosis. It specializes in the discovery, development, and commercialization of clean-surfaced nanotechnology (CSN) therapeutics. CNM-Au8, the lead asset, is a concentrated aqueous suspension of catalytically active, clean-surfaced, faceted gold nanocrystals. CNM-Au8’s mechanism of action targets mitochondrial dysfunction by catalyzing the production of nicotinamide adenine dinucleotide. Its CNM-ZnAg is a broad-spectrum antiviral, antibacterial agent comprised of zinc (Zn2+) and silver (Ag+) ions under development to treat infectious disease and to provide immune support for symptom resolution. Its CNM-AgZn17 is a gel polymer suspension of Zn2+ and Ag+ under development for the treatment of infectious diseases and to support wound healing.
Recently
Symbol
Price
%Change

Webull offers Clene Inc. stock information, including NASDAQ: CLNN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CLNN stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CLNN stock methods without spending real money on the virtual paper trading platform.